The John Hancock Small Cap Core Fund experienced a strong close to 2025, with its fourth-quarter performance exceeding the Russell 2000 Index. This positive outcome was largely attributed to astute stock selection in the industrial and information technology sectors, supported by robust corporate earnings and unexpectedly strong economic growth. Key contributors to this success included Exact Sciences Corp., a prominent cancer screening and diagnostics company, and MACOM Technology Solutions, Inc., a semiconductor manufacturer. However, some holdings, such as data protection software provider Commvault Systems, Inc., and nutritional products company BellRing Brands, Inc., faced headwinds. The fund's strategic emphasis on the IT sector, particularly in semiconductors and enterprise security software, remains a significant component of its portfolio.
Looking ahead, the fund’s management maintains a constructive outlook for JCCIX, focusing on high-quality investments that do not rely heavily on accelerated economic expansion. This strategy is further bolstered by the attractive valuations observed in the small-cap market and the declining trajectory of interest rates. The fund also made tactical adjustments to its sector allocations, rebalancing capital from healthcare and cash holdings into the industrial and consumer sectors to optimize its positioning for future growth.
In an ever-evolving market, a well-structured investment approach, characterized by meticulous stock selection and adaptable sector allocation, can pave the way for consistent growth. By focusing on fundamental strengths and responding to market shifts with strategic adjustments, investors can foster resilience and achieve long-term success. This proactive and discerning strategy underscores the potential for positive outcomes even amidst fluctuating economic conditions, highlighting the importance of informed decision-making in navigating the complexities of the financial landscape.
